Inspection Record

Isologic Innovative Radiopharmaceuticals of Ontario Limited — Health Canada Inspection Findings

Health CanadaInspected 2024-06-11 5 findingsContamination controlEquipment and facilityValidation and qualificationRegulatory reporting and change controlOther quality system

View the regulator's official source The source document is always the basis for judgement.

Findings

1Contamination control

The company did not adequately demonstrate that air-flow patterns did not pose a risk of contamination.

2Equipment and facility

Evaluation of production processes, equipment, and/or materials was inadequate.

3Validation and qualification

The number of personnel with the necessary qualifications and/or on-site experience was inadequate.

4Regulatory reporting and change control

The change control system was inadequate for ensuring changes are properly documented, evaluated, and/or approved.

5Other quality system

The implementation and/or the effectiveness of the sanitation program in preventing unsanitary conditions was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2024-06-11. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Isologic Innovative Radiopharmaceuticals of Ontario Limited findings history — including this company's other documents Health Canada documents, 2024 Go to Findings search